Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-18

Clinical Trial Update: Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating SK3530 for erectile dysfunction in men with diabetes mellitus has completed, sponsored by SK Chemicals Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SK3530

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED